|
SFRS4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.46610501516875E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.73859831981349E-11 |
| Normal-vs-Stage2 |
1.718340E-03 |
| Normal-vs-Stage3 |
1.21449999945789E-07 |
| Normal-vs-Stage4 |
2.74969999991548E-07 |
| Stage1-vs-Stage2 |
2.115000E-01 |
| Stage1-vs-Stage3 |
6.554800E-01 |
| Stage1-vs-Stage4 |
9.425800E-01 |
| Stage2-vs-Stage3 |
4.221200E-01 |
| Stage2-vs-Stage4 |
3.187000E-01 |
| Stage3-vs-Stage4 |
7.804400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.45929976172965E-11 |
| Normal-vs-AfricanAmerican |
4.35530000000295E-05 |
| Normal-vs-Asian |
4.156200E-03 |
| Caucasian-vs-AfricanAmerican |
5.234200E-01 |
| Caucasian-vs-Asian |
2.258300E-03 |
| AfricanAmerican-vs-Asian |
2.762200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.24090001899447E-09 |
| Normal-vs-Female |
1.91491267287347E-12 |
| Male-vs-Female |
5.580400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.314060E-02 |
| Normal-vs-Age(41-60Yrs) |
6.66910970892332E-12 |
| Normal-vs-Age(61-80Yrs) |
3.02570002386204E-09 |
| Normal-vs-Age(81-100Yrs) |
7.142400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.663600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.849600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.985600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.379020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.668030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.184400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.66409996893435E-10 |
| Normal-vs-Grade 2 |
7.11120051732905E-12 |
| Normal-vs-Grade 3 |
4.94959999652878E-08 |
| Normal-vs-Grade 4 |
2.09459999999106E-05 |
| Grade 1-vs-Grade 2 |
1.048250E-02 |
| Grade 1-vs-Grade 3 |
5.229700E-04 |
| Grade 1-vs-Grade 4 |
1.275540E-02 |
| Grade 2-vs-Grade 3 |
4.343600E-02 |
| Grade 2-vs-Grade 4 |
4.827000E-01 |
| Grade 3-vs-Grade 4 |
5.265600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.63347113613099E-12 |
| Normal-vs-ccB subtype |
1.193250E-04 |
| ccA subtype-vs-ccB subtype |
1.202090E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.76549999567166E-08 |
| Normal-vs-N1 |
4.672300E-02 |
| N0-vs-N1 |
4.638600E-01 |
|
|
